1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,097 | 0,129 | 12:14 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.09. | hVIVO PLC - Notice of Results | 4 | RNS | ||
| 01.09. | hVIVO appoints Avacta Chair Shaun Chilton to lead board | 1 | Alliance News | ||
| 01.09. | hVIVO PLC - Appointment of Non-Executive Chair | - | RNS | ||
| 29.07. | hVIVO PLC - Proposed appointment of Chair | - | RNS | ||
| HVIVO Aktie jetzt für 0€ handeln | |||||
| 22.07. | TRADING UPDATES & EARNINGS: hVIVO expects interim revenue decline | 2 | Alliance News | ||
| 22.07. | hVIVO PLC - H1 Trading update | 1 | RNS | ||
| 18.07. | hVIVO PLC - Directorate Change | - | RNS | ||
| 09.07. | hVIVO PLC - Notice of Trading Update | - | RNS | ||
| 30.06. | hVivo reports positive results from its largest lab contract to date | 1 | Sharecast | ||
| 30.06. | hVIVO reports positive results from Cidara's Phase 2b influenza study | 3 | Investing.com | ||
| 30.06. | hVIVO PLC - Positive results from client Phase 2b field study | - | RNS | ||
| 05.06. | hVIVO PLC - Result of AGM | - | RNS | ||
| 02.06. | DIRECTOR DEALINGS: hVIVO CEO buys shares; Investec execs sell stock | 2 | Alliance News | ||
| 02.06. | hVIVO PLC - Director/PDMR Shareholding | - | RNS | ||
| 30.05. | hVIVO stock plunges after contract cancellations in 'depressed' market | 1 | Alliance News | ||
| 30.05. | Hvivo shares tank after contract cancellations | 4 | Shares | ||
| 30.05. | AIM WINNERS & LOSERS: hVIVO shares dive on contract cancellations | 1 | Alliance News | ||
| 30.05. | Hvivo client cancels 'significant' HCT trial contract | 1 | Sharecast | ||
| 30.05. | hVIVO PLC - Trading update | - | RNS | ||
| 29.05. | hVIVO PLC - Appointment of Independent Non-Executive Director | - | RNS |
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 0,415 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Regains Compliance with Applicable Nasdaq Listing Criteria | HOUSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform... ► Artikel lesen | |
| JD HEALTH INTERNATIONAL | 7,400 | -0,67 % | Leichter Wertverlust bei der JD Health-Aktie (7,65 €) | Die JD Health-Aktie notiert heute ein wenig leichter. Der jüngste Kurs betrug 7,65 Euro. Heute hat sich am Aktienmarkt das Wertpapier von JD Health zwischenzeitlich um 1,92 Prozent verbilligt. Der Kurs... ► Artikel lesen | |
| LIFEWARD | 0,549 | 0,00 % | Lifeward Ltd.: Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
| EKSO BIONICS | 3,970 | 0,00 % | EKSO BIONICS HOLDINGS, INC. - 8-K, Current Report | ||
| IMUNON | 4,300 | +0,47 % | Imunon, Inc.: IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement | LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Company... ► Artikel lesen | |
| BIOCEPT | 7,200 | 0,00 % | GlaxoSmithKline Bioc: Gewinn im zweiten Quartal bei 5,9 Mio. EGP | ||
| ROCKWELL MEDICAL | 1,380 | +1,62 % | ROCKWELL MEDICAL, INC. - S-8, Securities to be offered to employees in employee benefit plans | ||
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| VIRIDIAN THERAPEUTICS | 15,560 | -1,18 % | These Analysts Revise Their Forecasts On Viridian Therapeutics Following Q2 Results | ||
| SINTX TECHNOLOGIES | 3,930 | 0,00 % | SINTX Technologies, Inc.: SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent | Significant Development in the Estimated $30 Billion Global Infection-Prevention Market SALT LAKE CITY, Utah, Sept. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX"... ► Artikel lesen | |
| AETHLON MEDICAL | 1,430 | -100,00 % | Stocks Moving Premarket: Aethlon Medical, Tharimmune, Brazil Potash And Other Gainers & Losers | OTTAWA (dpa-AFX) - At 7:32 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.08.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 28.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.08.2025.ISIN NameAU000000DHG9 DOMAIN... ► Artikel lesen | |
| SAVARIA | 12,800 | 0,00 % | Savaria Corp: Savaria increases monthly dividend to 4.67 cents | ||
| NEURONETICS | 2,410 | 0,00 % | Neuronetics: New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar Advanced Therapy, to Treat Major Depressive Disorder (MDD) | ||
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report |
HVIVO PLC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,021 (-22,46 %) liegt der Kurs bei 0,073 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HVIVO PLC finden Sie auf Wallstreet Online.